122 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4RY

Akeso
HK$5.550%25.0%HK$41.0bHK$7.04PE18.7xE10.9%n/a

RIG2

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Ft23.80-2.9%8.8%Ft1.7tFt30.52PE8.9xE16.1%4.6%

640

China Resources Pharmaceutical Group
HK$0.70-2.8%-17.1%HK$38.1bn/aPE9.2xE7.0%2.7%

2M7C

China Medical System Holdings
HK$0.78-8.3%-45.4%HK$16.5bHK$1.25PE6.4xE6.8%6.2%

29A

Amphastar Pharmaceuticals
US$38.101.1%-6.6%US$2.0bUS$54.88PE13.7xE16.8%n/a

82P

Pacira BioSciences
US$28.400.7%-24.5%US$1.4bUS$41.51PE20.3xE29.9%n/a

ICY

Incyte
US$52.740.3%-12.4%US$12.9bUS$66.74PE17.5xE17.8%n/a

7K90

Asymchem Laboratories (Tianjin)
CN¥6.90-4.8%-43.9%CN¥27.9bCN¥8.52PE14.9xE4.6%2.2%

MX6A

Grand Pharmaceutical Group
HK$0.55-2.7%-3.5%HK$16.9bn/aPE9xE13.9%5.4%

RPD

Royalty Pharma
US$24.98-2.9%-15.8%US$16.2bUS$41.82PE15.4xE12.5%3.1%

RV6

Charles River Laboratories International
US$203.40-5.1%11.1%US$11.4bUS$246.68PE25.4xE13.6%n/a

JNJ0

Johnson & Johnson
US$13.300%n/aUS$364.0bUS$14.99PE21.6xE6.9%3.2%

AB3A

Sarepta Therapeutics
US$118.35-3.0%-8.6%US$12.2bUS$155.14PE717.7xE35.6%n/a

CVG

CSPC Pharmaceutical Group
HK$0.76-2.6%-11.5%HK$77.1bHK$1.10PE12.2xE4.4%4.3%

GE9

Genmab
kr.273.600.6%-27.4%kr.132.7bkr.328.29PE24.3xE20.4%n/a

R2WA

Beximco Pharmaceuticals
৳0.440%3.8%৳49.8bn/aPE9.3xE15.6%3.1%

C1S

China Shineway Pharmaceutical Group
HK$1.06-6.2%0%HK$6.9bHK$1.63PE6.6xE14.5%6.3%

GE91

Genmab
kr.27.601.5%-27.0%kr.132.7bkr.33.12PE24.3xE20.4%n/a

GEKA

Genomma Lab Internacional. de
Mex$0.90-1.1%18.5%Mex$15.8bMex$1.05PE15.1xE28.6%4.7%

1FW1

WuXi Biologics (Cayman)
HK$3.00-8.0%-70.3%HK$54.7bHK$6.22PE14.9xE14.1%n/a

UTH

United Therapeutics
US$252.001.9%26.6%US$12.2bUS$268.16PE11.7xE6.7%n/a

I7G0

Ipsen
€29.000%8.2%€10.1b€29.98PE16.4xE6.3%1.0%

P731

Medexus Pharmaceuticals
CA$1.061.0%24.0%CA$39.6mCA$2.13PE4.9xE46.9%n/a

83B

3SBio
HK$0.69-4.8%-23.8%HK$15.0bn/aPE9xE12.7%3.9%
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.